Erratum for Rao SV. “Strategies to Reduce Bleeding Among Patients with Ischemic Heart Disease Treated with Antiplatelet Therapies” Am J Cardiol 2009;104(suppl):60C–63C




The sentence in the first paragraph that begins “However, among the 30 patients who did undergo CABG,” in reference to the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel–Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38) trial, misstates the number of patients who underwent coronary artery bypass grafting (CABG) in that trial; the actual number was 437.

Only gold members can continue reading. Log In or Register to continue

Related posts:

  1. Comparison by Meta-Analysis of Eptifibatide and Tirofiban to Abciximab in Patients With ST-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
  2. Usefulness of Cardiorespiratory Fitness to Predict Coronary Heart Disease Risk Independent of Physical Activity
  3. Mortality in the TRITON Trial: Update from the FDA Prasugrel Action Package
  4. Some Previously Neglected Examples of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy and Frequency of Its Various Reported Manifestations

Stay updated, free articles. Join our Telegram channel
Tags:
Dec 22, 2016 | Posted by in CARDIOLOGY | Comments Off on Erratum for Rao SV. “Strategies to Reduce Bleeding Among Patients with Ischemic Heart Disease Treated with Antiplatelet Therapies” Am J Cardiol 2009;104(suppl):60C–63C

Full access? Get Clinical Tree
Get Clinical Tree app for offline access